Quarterly report (Form 10-Q)
West Pharmaceutical Services 10-Q for Quarter ended Jun 30, 2026
Filing excerpt
West Vantage gross profit margin decreased by 3.3 percentage points for the three months ended June 30, 2026, as compared to the same period in 2025, due to inefficiencies associated with production downtime related to the Company’s May 2026 cyber incident, as well as inflationary pressures on our plant spend, partially offset by sales price increases.